Certificate under SEBI (Depositories and Participants) Regulations, 2018

To To Date: July 13, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Confirmation as per Regulation 74(5) of SEBI (DP) Regulations. Dear Sir/Madam, With reference to the above and based on the certificate’s received from our R&T agents i.e MUFG Intime India Private Limited, we would like to confirm that the details of securities dematerialized / rematerialized during the quarter ended on 30.06.2026 have been furnished to all the stock exchanges where the equity shares of the Company are listed, within the prescribed time limit. The Share certificates received for dematerialization, if any has been mutilated and cancelled after due verification and the name of the depository has been substituted in the records as registered owner, within 15 days of the receipt of the certificate of security. Please takes this intimation on your records Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681